Offshore Technology on MSN

Intensity, Rainbow set to proceed with phase one of North Dakota gas pipeline

Intensity Infrastructure Partners and Rainbow Energy Center have confirmed their intention to move forward with phase one of ...
Nasdaq

Xilio Therapeutics to Present Updated Phase 2 Data for Vilastobart at ASCO 2025, Advancing Tumor-Activated Immuno-Oncology Pipeline

Xilio Therapeutics, a clinical-stage biotechnology company, announced progress on its pipeline and first-quarter financial results, highlighting initial Phase 2 data for vilastobart, a tumor-activated ...
The Manila Times

Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline

U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures ...
FierceBiotech

Pfizer's parade of pipeline cuts: Seagen, BioNTech and MASH programs among 11 axed

Pfizer has axed 11 programs including two pipeline assets from its $43 billion Seagen acquisition, work on a BioNTech-partnered mRNA vaccine and a midstage metabolic dysfunction-associated ...
The Manila Times

Madrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor

Agreement expands Madrigal’s pipeline and strengthens its leadership in pioneering MASH therapiesDGAT-2 inhibition represents a complementary mechanism of action with Rezdiffra® (resmetirom) for ...